Zheng C, Wang Y, Cheng Y, Wang X, Wei H, King I
Brief Bioinform. 2024; 25(3).
PMID: 38555470
PMC: 10981759.
DOI: 10.1093/bib/bbae112.
Shen Q, Hill T, Cai X, Bui L, Barakat R, Hills E
Cancer Lett. 2021; 506:142-151.
PMID: 33639204
PMC: 8112468.
DOI: 10.1016/j.canlet.2021.01.020.
Yang Y, Nguyen T, Pereira I, Hur J, Kim H
Biomolecules. 2019; 9(12).
PMID: 31795147
PMC: 6995618.
DOI: 10.3390/biom9120797.
Kasten B, Ferrone S, Zinn K, Buchsbaum D
Curr Med Chem. 2019; 27(24):4016-4038.
PMID: 30836909
PMC: 8668195.
DOI: 10.2174/0929867326666190228120908.
Kasten B, Gangrade A, Kim H, Fan J, Ferrone S, Ferrone C
Nucl Med Biol. 2018; 58:67-73.
PMID: 29413459
PMC: 5817013.
DOI: 10.1016/j.nucmedbio.2017.12.004.
The functional curcumin liposomes induce apoptosis in C6 glioblastoma cells and C6 glioblastoma stem cells in vitro and in animals.
Wang Y, Ying X, Xu H, Yan H, Li X, Tang H
Int J Nanomedicine. 2017; 12:1369-1384.
PMID: 28260885
PMC: 5325138.
DOI: 10.2147/IJN.S124276.
B7-H3-targeted Pb radioimmunotherapy of ovarian cancer in preclinical models.
Kasten B, Arend R, Katre A, Kim H, Fan J, Ferrone S
Nucl Med Biol. 2017; 47:23-30.
PMID: 28104527
PMC: 5340614.
DOI: 10.1016/j.nucmedbio.2017.01.003.
Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy.
Komorowski M, McGray A, Kolakowska A, Eng K, Gil M, Opyrchal M
Mol Ther Oncolytics. 2016; 3:16034.
PMID: 28035333
PMC: 5155641.
DOI: 10.1038/mto.2016.34.
Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells.
Guimaraes D, Almeida L, Martins M, Warner K, Silva A, Vargas P
Oncotarget. 2016; 7(27):42447-42460.
PMID: 27285758
PMC: 5173147.
DOI: 10.18632/oncotarget.9884.
Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.
Shang J, Ling X, Zhang L, Tang Y, Xiao Z, Cheng Y
Eur J Nucl Med Mol Imaging. 2016; 43(11):1945-53.
PMID: 27236466
DOI: 10.1007/s00259-016-3420-7.
Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cells.
Carstens M, Fisher R, Acharya A, Butterworth E, Scott E, Huang E
Proc Natl Acad Sci U S A. 2015; 112(28):8732-7.
PMID: 26124098
PMC: 4507198.
DOI: 10.1073/pnas.1505374112.
TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis.
Nuti S, Mor G, Li P, Yin G
Oncotarget. 2014; 5(17):7260-71.
PMID: 25238494
PMC: 4202121.
DOI: 10.18632/oncotarget.2428.
Multiple blocks in the engagement of oxidative phosphorylation in putative ovarian cancer stem cells: implication for maintenance therapy with glycolysis inhibitors.
Alvero A, Montagna M, Sumi N, Joo W, Graham E, Mor G
Oncotarget. 2014; 5(18):8703-15.
PMID: 25237928
PMC: 4226715.
DOI: 10.18632/oncotarget.2367.
Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.
Craveiro V, Yang-Hartwich Y, Holmberg J, Joo W, Sumi N, Pizzonia J
Cancer Med. 2014; 2(6):751-62.
PMID: 24403249
PMC: 3892380.
DOI: 10.1002/cam4.115.
Expression of betapapillomavirus oncogenes increases the number of keratinocytes with stem cell-like properties.
Hufbauer M, Biddle A, Borgogna C, Gariglio M, Doorbar J, Storey A
J Virol. 2013; 87(22):12158-65.
PMID: 24006432
PMC: 3807911.
DOI: 10.1128/JVI.01510-13.
Antitumor effect of embryonic stem cells in a non-small cell lung cancer model: antitumor factors and immune responses.
Dong W, Qiu C, Shen H, Liu Q, Du J
Int J Med Sci. 2013; 10(10):1314-20.
PMID: 23983591
PMC: 3752719.
DOI: 10.7150/ijms.6538.
Biological characteristics of CD133(+) cells in nasopharyngeal carcinoma.
Zhuang H, Mo T, Hou W, Xiong G, Zhu X, Fu Q
Oncol Rep. 2013; 30(1):57-63.
PMID: 23604326
PMC: 3729244.
DOI: 10.3892/or.2013.2408.
CD133 antisense suppresses cancer cell growth and increases sensitivity to cisplatin in vitro.
Blancas-Mosqueda M, Zapata-Benavides P, Zamora-Avila D, Saavedra-Alonso S, Manilla-Munoz E, Franco-Molina M
Exp Ther Med. 2012; 4(5):901-905.
PMID: 23226746
PMC: 3493786.
DOI: 10.3892/etm.2012.692.
Effect of RNA interference-related HiWi gene expression on the proliferation and apoptosis of lung cancer stem cells.
Liang D, Fang Z, Dong M, Liang C, Xing C, Zhao J
Oncol Lett. 2012; 4(1):146-150.
PMID: 22807978
PMC: 3398372.
DOI: 10.3892/ol.2012.677.
Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer.
Steffensen K, Alvero A, Yang Y, Waldstrom M, Hui P, Holmberg J
J Oncol. 2011; 2011:620523.
PMID: 21904548
PMC: 3166719.
DOI: 10.1155/2011/620523.
